RURO, Inc. confirms that Limfinity® was developed and verified with respect to the compliance with the USA and OECD Ordinance on Good Laboratory Practice.
This is based on FDA Good Laboratory Practice (GLP) introduced in 1979 and the Organization for Economic Co-operation and Development (OECD) principles of GLP as revised in 1997 and adopted on 26th November 1997 by decision of the OECD Council [C(97)186/Final].
RURO, Inc. confirms that customers using Limfinity® software are able to conduct studies in compliance with principles of GLP.
Limifinty® has been designed following a third party audited, industry leading SDLC (software development life-cycle) that ensures consistency in the design and performance of all Limifinty® based applications. Like all of the GxP’s, GLP compliance is the ultimate responsibility of the regulated entity, however, with 21 CFR Part 11 compliant audit trails and electronic signatures Limfinity® applications enable GLP regulated organizations to achieve compliance. Limfinity® can be configured and validated to meet any regulatory use case within the laboratory.